Cardiovascular Drugs Practice Questions

Q: In a patient with concomitant diabetes, what is the anti-hypertensive agent of choice?

ACE inhibitor. **Explanation:** **1. Why ACE Inhibitors are the Correct Choice:** ACE inhibitors (e.g., Enalapril, Ramipril) are the drugs of choice for hypertensive patients with diabetes mellitus primarily due to their **renoprotective effects**. They cause preferential dilatation of the **efferent arteriole** in the kidney, which reduces intraglomerular pressure. This mechanism effectively slows the progression of diabetic nephropathy and reduces albuminuria (microalbuminuria). Additionally, ACE inhibitors are metabolically neutral and may slightly improve insulin sensitivity. **2. Why Other Options are Incorrect:** * **Calcium Channel Blockers (CCBs):** While CCBs (like Amlodipine) are metabolically neutral and effective anti-hypertensives, they do not offer the same level of superior renal protection as ACE inhibitors or ARBs. They are considered second-line or add-on therapy. * **Beta Adrenergic Blockers:** These are generally avoided as first-line therapy in diabetics because they can **mask the warning symptoms of hypoglycemia** (tachycardia, tremors) and may impair glucose tolerance by inhibiting insulin release. * **Plasma Kinins:** These are endogenous peptides (like bradykinin) involved in inflammation and vasodilation. They are not used as pharmacological agents for treating hypertension. **3. NEET-PG High-Yield Pearls:** * **Drug of Choice (DOC):** If a patient has both Diabetes and Hypertension, the first choice is an **ACE Inhibitor**. If the patient develops a dry cough (due to bradykinin accumulation), switch to an **ARB** (Losartan/Telmisartan). * **Mechanism:** ACE inhibitors reduce **Proteinuria**, which is the hallmark of diabetic kidney disease. * **Contraindications:** Never prescribe ACE inhibitors or ARBs during **pregnancy** (teratogenic) or in patients with **Bilateral Renal Artery Stenosis**. * **Electrolyte Watch:** Always monitor for **Hyperkalemia** when starting these drugs.

Q: Nitrates cannot be used in which of the following conditions?

Renal colic. **Explanation:** Nitrates are potent smooth muscle relaxants that act by releasing Nitric Oxide (NO), which increases cGMP levels. However, their efficacy varies across different organ systems. **Why Renal Colic is the Correct Answer:** Nitrates are **ineffective in renal colic** because the ureteric smooth muscle lacks the specific metabolic machinery or sufficient sensitivity to respond to nitrate-induced relaxation. In clinical practice, renal colic is managed with NSAIDs (to decrease prostaglandin-mediated pressure) and antispasmodics like hyoscine or tamsulosin. **Analysis of Incorrect Options:** * **Angina Pectoris:** This is the primary indication for nitrates. They cause peripheral vasodilation (venodilation > arteriodilation), which decreases preload and myocardial oxygen demand. * **Biliary Colic:** Nitrates effectively relax the **Sphincter of Oddi** and the smooth muscles of the biliary tract, providing symptomatic relief in biliary spasms. * **Cyanide Poisoning:** Amyl nitrite and sodium nitrite are used as antidotes. They induce **methemoglobinemia**; methemoglobin has a high affinity for cyanide, forming cyanmethemoglobin and preventing cyanide from binding to cytochrome oxidase. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** For acute angina, sublingual Nitroglycerin (GTN) is the DOC. * **Nitrate Tolerance:** Continuous use leads to "tachyphylaxis" due to the depletion of free sulfhydryl (-SH) groups. A "nitrate-free interval" of 8–12 hours (usually at night) is required to prevent this. * **Monday Disease:** Workers in dynamite factories experience headaches and dizziness on Mondays due to sudden re-exposure to nitrates after a weekend break. * **Contraindication:** Never co-administer nitrates with **Sildenafil** (PDE-5 inhibitors) as it can lead to life-threatening hypotension.

Q: Betaxolol is a:

beta blocker. **Explanation:** **Betaxolol** is a highly selective **$\beta_1$-adrenergic receptor antagonist** (cardioselective beta-blocker). It works by competitively inhibiting the action of catecholamines on $\beta_1$ receptors located primarily in the heart and the juxtaglomerular apparatus of the kidney [1]. * **Why Option B is Correct:** Betaxolol belongs to the second generation of beta-blockers [1]. Its high selectivity for $\beta_1$ receptors makes it useful in treating hypertension and glaucoma while minimizing side effects related to $\beta_2$ blockade (like bronchospasm). * **Why Option A is Incorrect:** Alpha-blockers (e.g., Prazosin, Phenoxybenzamine) act on $\alpha$-adrenergic receptors [2]. Betaxolol has no significant $\alpha$-blocking activity. * **Why Option C is Incorrect:** Calcium channel blockers (e.g., Amlodipine, Verapamil) inhibit the influx of calcium ions into cardiac and smooth muscle cells. While they are also used for hypertension, their mechanism of action is distinct from beta-blockers. **High-Yield Clinical Pearls for NEET-PG:** 1. **Glaucoma Management:** Betaxolol is unique because it is one of the few **cardioselective** beta-blockers available as an ophthalmic solution. It reduces intraocular pressure by decreasing aqueous humor production. 2. **Safety Profile:** Due to its $\beta_1$ selectivity, it is preferred over non-selective blockers (like Timolol) in patients with mild respiratory issues, though caution is still advised in severe asthma/COPD. 3. **Pharmacokinetics:** It has a long half-life (~14–22 hours), allowing for convenient once-daily dosing. 4. **Membrane Stabilizing Activity (MSA):** Betaxolol possesses slight MSA, but it lacks Intrinsic Sympathomimetic Activity (ISA).

Q: Which of the following is associated with a prolonged QT interval?

Type Ia antiarrhythmic drugs. **Explanation:** The **QT interval** on an ECG represents the duration of ventricular depolarization and repolarization. Prolongation of this interval is primarily caused by a delay in ventricular repolarization, usually due to the inhibition of outward potassium ($K^+$) currents. **Why Option B is Correct:** **Type Ia antiarrhythmic drugs** (e.g., Quinidine, Procainamide, Disopyramide) act by blocking fast sodium ($Na^+$) channels, but they also possess significant **potassium channel blocking** properties. By inhibiting the efflux of $K^+$ during phase 3 of the cardiac action potential, they delay repolarization, thereby lengthening the action potential duration (APD) and the QT interval. **Analysis of Incorrect Options:** * **A. Hypercalcemia:** High calcium levels actually **shorten** the QT interval by accelerating the plateau phase (Phase 2) of the action potential. Conversely, *hypocalcemia* causes QT prolongation. * **C. Torsade de pointes (TdP):** This is a **consequence**, not a cause, of a prolonged QT interval. TdP is a specific type of polymorphic ventricular tachycardia that occurs when a prolonged QT interval leads to early after-depolarizations (EADs). * **D. Atrial fibrillation:** This is a supraventricular tachyarrhythmia characterized by disorganized atrial electrical activity. While it affects the rhythm and the absence of P-waves, it does not inherently prolong the QT interval. **NEET-PG High-Yield Pearls:** * **Mnemonic for QT Prolonging Drugs (ABCDE):** **A**ntiarrhythmics (Class Ia & III), **B**iotics (Macrolides, Fluoroquinolones), **C**yps (Antipsychotics/Haloperidol), **D**epressants (TCAs, SSRIs), **E**metics (Ondansetron). * **Electrolyte triggers:** Hypokalemia, hypomagnesemia, and hypocalcemia all prolong the QT interval. * **Treatment of TdP:** Intravenous **Magnesium Sulfate** is the drug of choice, even if serum magnesium levels are normal.

Q: Which of the following is true regarding enalapril treatment in patients of essential hypertension?

Decreased angiotensin II concentration in the blood. **Explanation:** Enalapril is an **ACE (Angiotensin-Converting Enzyme) Inhibitor**. To understand its effects, one must look at the Renin-Angiotensin-Aldosterone System (RAAS) pathway. **1. Why Option A is Correct:** ACE inhibitors directly block the enzyme responsible for converting Angiotensin I into **Angiotensin II**. Therefore, the primary biochemical effect of enalapril is a significant **decrease in circulating Angiotensin II levels**. This leads to vasodilation and decreased peripheral resistance. **2. Why the other options are incorrect:** * **Option B:** ACE inhibitors actually **increase plasma renin levels**. Because Angiotensin II levels fall, the negative feedback loop on the juxtaglomerular cells is lost, leading to a compensatory rise in renin secretion (pro-renin to renin). * **Option C:** By decreasing Angiotensin II, there is a subsequent decrease in **Aldosterone** secretion. Since aldosterone normally causes sodium reabsorption and potassium excretion, inhibiting it leads to **increased sodium excretion (natriuresis)** and **decreased potassium excretion** in the urine. This results in a risk of hyperkalemia, not increased potassium in the urine. **High-Yield Clinical Pearls for NEET-PG:** * **Bradykinin:** ACE inhibitors also inhibit the breakdown of bradykinin. Increased bradykinin levels are responsible for the classic side effects: **Dry cough** and **Angioedema**. * **Teratogenicity:** ACE inhibitors are strictly contraindicated in pregnancy as they cause **fetal renal anomalies** (Potter sequence). * **Drug of Choice:** They are the first-line treatment for hypertension in patients with **Diabetes Mellitus** (due to nephroprotective effects) and **Heart Failure** (reduces remodeling). * **First-dose phenomenon:** Watch out for sudden hypotension after the first dose, especially in patients on diuretics.

Q: Which of the following fibrinolytic agents is antigenic?

Streptokinase. **Explanation:** The correct answer is **Streptokinase**. **1. Why Streptokinase is the correct answer:** Streptokinase is a protein derived from **Group C Beta-hemolytic Streptococci**. Because it is a bacterial product and not a human enzyme, the human immune system recognizes it as a foreign antigen. This leads to the production of antistreptococcal antibodies. * **Clinical Significance:** These antibodies can cause hypersensitivity reactions (ranging from rashes to anaphylaxis) and can neutralize the drug, making it ineffective if administered again within 6 months to a year of the initial dose or a recent streptococcal infection. **2. Why the other options are incorrect:** * **Urokinase:** It is a human enzyme naturally synthesized by the kidneys and found in urine. Since it is of human origin, it is non-antigenic. * **Alteplase (rt-PA):** This is a recombinant form of human tissue-type plasminogen activator [1]. Being identical to endogenous human t-PA, it does not elicit an immune response. * **Tenecteplase:** This is a genetically engineered mutant of Alteplase with a longer half-life and higher fibrin specificity [1]. Despite the modifications, it remains non-antigenic. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Streptokinase is an **indirect** plasminogen activator; it forms a 1:1 complex with plasminogen to activate it. In contrast, Alteplase and Tenecteplase are **direct** activators [1]. * **Fibrin Specificity:** Streptokinase is **non-fibrin specific**, leading to a "systemic lytic state" and a higher risk of bleeding compared to the fibrin-specific agents (Tenecteplase > Reteplase > Alteplase) [1]. * **Side Effect:** Hypotension is a common side effect unique to Streptokinase infusion. * **Drug of Choice:** Tenecteplase is currently the preferred agent for STEMI due to its bolus dosing and high fibrin specificity [1].

Q: Which of the following drugs decreases heart rate?

Propranolol. **Explanation:** The heart rate is primarily regulated by the autonomic nervous system acting on **$\beta_1$-adrenergic receptors** located in the SA node. **Propranolol (Correct Answer):** Propranolol is a **non-selective $\beta$-blocker** (antagonist). By blocking $\beta_1$ receptors in the heart, it inhibits the stimulatory effects of catecholamines, leading to a decrease in the slope of Phase 4 depolarization in pacemaker cells. This results in **negative chronotropy** (decreased heart rate) and negative inotropy (decreased contractility). **Why the other options are incorrect:** * **Isoprenaline:** A potent non-selective $\beta$-agonist ($\beta_1$ and $\beta_2$). It significantly **increases** heart rate by stimulating $\beta_1$ receptors. * **Dopamine:** At moderate to high doses, dopamine stimulates $\beta_1$ receptors (directly and via norepinephrine release), causing an **increase** in heart rate. * **Dobutamine:** A relatively selective $\beta_1$-agonist used as an inotropic agent. While its primary effect is increasing contractility, it also **increases** heart rate. **High-Yield NEET-PG Pearls:** * **Drug of Choice (DOC):** Propranolol is the DOC for performance anxiety (stage fright) and prophylaxis of migraine. * **Contraindication:** Avoid $\beta$-blockers in patients with **Bronchial Asthma** (due to $\beta_2$ blockade causing bronchospasm) and **Prinzmetal Angina** (due to unopposed $\alpha$-mediated vasoconstriction). * **Membrane Stabilizing Activity:** Propranolol possesses significant local anesthetic activity, though it is not used clinically for this purpose. * **Bradycardia Management:** If a $\beta$-blocker overdose causes symptomatic bradycardia, the specific antidote is **Glucagon**.

Question 1

In a patient with concomitant diabetes, what is the anti-hypertensive agent of choice?

Accepted Answer

ACE inhibitor

Answer

Calcium channel blocker

Answer

Beta adrenergic blocker

Answer

Plasma kinins

Question 2

All of the following statements about the antianginal action of nitrates are true EXCEPT?

Accepted Answer

Increased total coronary flow

Answer

Decreased myocardial O2 consumption

Answer

Decreased both preload and afterload

Answer

Cause favorable redistribution of coronary flow

Question 3

Nitrates cannot be used in which of the following conditions?

Accepted Answer

Renal colic

Answer

Angina pectoris

Answer

Biliary colic

Answer

Cyanide poisoning

Question 4

Betaxolol is a:

Accepted Answer

beta blocker

Answer

alpha blocker

Answer

calcium channel blocker

Answer

None of the above

Question 5

Which of the following is associated with a prolonged QT interval?

Accepted Answer

Type Ia antiarrhythmic drugs

Answer

Hypercalcemia

Answer

Torsade de pointes

Answer

Atrial fibrillation

Question 6

Which of the following is true regarding enalapril treatment in patients of essential hypertension?

Accepted Answer

Decreased angiotensin II concentration in the blood

Answer

Decreased concentration of renin in the blood

Answer

Decreases sodium and increases potassium in the urine

Answer

All of the above

Question 7

Ibutilide acts by

Accepted Answer

Interference with the action of catecholamines at the beta-adrenergic receptor

Answer

Blockade of Na+ current

Answer

Delay of repolarization due to inhibition of K+ current

Answer

Interference with calcium conductance

Question 8

Which of the following statements is relevant when deciding to treat a patient with procainamide?

Accepted Answer

Procainamide prolongs the effective refractory period in atrial and ventricular cells.

Answer

Procainamide may worsen or precipitate hyperthyroidism.

Answer

Procainamide is not effective for atrial arrhythmias.

Answer

Procainamide commonly induces thrombocytopenia.

Question 9

Which of the following fibrinolytic agents is antigenic?

Accepted Answer

Streptokinase

Answer

Urokinase

Answer

Alteplase

Answer

Tenecteplase

Question 10

Which of the following drugs decreases heart rate?

Accepted Answer

Propranolol

Answer

Isoprenaline

Answer

Dopamine

Answer

Dobutamine

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?